University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 2 of 16
Elranatamab in Relapsed/Refractory Multiple Myeloma
NCT06711705
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
NCT06639724
Intervening on Women's Health for Rural Young Cancer Survivors
NCT06664034
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
NCT06582888
BladdEr Full OR Empty for Pelvic Radiation Therapy
NCT06651697
Meditative Neurofeedback for Depression
NCT06675240
Total RadIoTherapy of Oligometastatic caNcerS
NCT06587490
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
NCT06665971
Ketogenic Diet and Brain Response in Anorexia Nervosa
NCT06540703
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
NCT06273527
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
NCT06706856
Women Focused Encounters for Resilience Independence Strength and Eudaimonia
NCT06216600
Coenzyme Q10 for Gulf War Illness: A Replication Study
NCT06515184
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
NCT05696366
Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction
NCT06540105
THC Effects on Glucose in Type 2 Diabetes
NCT05322213
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
NCT06981234
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
NCT06721975
Pilot Study of Preoperative Intestinal Training Using Antegrade Ileostomy Infusion
NCT06461559
Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa
NCT06566612
Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes
NCT06398093
Short-term And Longer-term Cognitive Impact Of Neurochecks
NCT06219889
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
NCT06205849
Effects of Hypoxic Breathwork
NCT06317259
A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty
NCT07282782
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
NCT06482268
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
NCT06393101
Mindfulness Engaged Neurostimulation for Depression
NCT06399406
Pramipexole to Enhance Social Connections
NCT06269146
Family, Responsibility, Education, Support, and Health for Food Responsiveness
NCT06207110
Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)
NCT05787639
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
NCT06385236
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
NCT05237505
Focal Therapy for Localized Prostate Cancer
NCT06270043
Multisite Implementation of COMPRENDO
NCT06055296
Time Restricted Eating in Sleep Apnea
NCT06047496
Enhancing Team Effectiveness for a Collaborative School-based Intervention for ADHD
NCT06180681
Multi-Omics for Maternal Health After Preeclampsia
NCT06340152
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
NCT06579417
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
NCT05705219
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
NCT05882253
Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants
NCT06123143
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
NCT06128304
Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
NCT06577883
Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
NCT06311123
Therapeutic Ketogenic Diet in Anorexia Nervosa
NCT06000774
Effect of Anti-inflammatory Diet in Osteoarthritis
NCT06080347
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
NCT05682677
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
NCT05514899
Effect of Mediterranean Diet in Inflammatory Bowel Disease
NCT05973500
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, San Diego pipeline card: 775 registered trials from official public datasets.Report a data error.